appropri
antimicrobi
treatment
communityacquir
pneumonia
cap
base
distribut
aetiolog
pathogen
antimicrobi
resist
major
pathogen
clinic
characterist
outcom
perform
prospect
observ
studi
case
adult
cap
hospit
eight
asian
countri
microbiolog
evalu
determin
etiolog
pathogen
well
clinic
evalu
perform
bronchopulmonari
diseas
frequent
underli
diseas
follow
cardiovascular
diseas
correspond
author
tel
fax
malign
neurolog
disord
streptococcu
pneumonia
common
isol
follow
klebsiella
pneumonia
haemophilu
influenza
serolog
test
posit
mycoplasma
pneumonia
chlamydia
pneumonia
posit
legionella
pneumophila
urinari
antigen
test
pneumococc
isol
resist
erythromycin
suscept
penicillin
seventeen
percent
cap
mix
infect
especi
pneumonia
c
pneumonia
overal
mortal
rate
nurs
home
resid
mechan
ventil
malign
cardiovascular
diseas
respiratori
rate
hyponatraemia
signific
independ
risk
factor
mortal
multivari
analysi
p
current
data
provid
relev
inform
pathogen
distribut
antimicrobi
resist
major
pathogen
cap
well
clinic
outcom
ill
asian
countri
communityacquir
pneumonia
cap
still
remain
one
import
caus
death
especi
older
adult
comorbid
diseas
despit
advanc
modern
medicin
sinc
cap
condit
signific
mortal
morbid
earli
effect
antimicrobi
treatment
major
focu
clinic
practic
pathogen
distribut
antimicrobi
resist
major
pathogen
local
set
import
select
appropri
antibiot
treatment
cap
major
identifi
pathogen
cap
includ
streptococcu
pneumonia
haemophilu
influenza
atyp
pathogen
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
spp
howev
distribut
aetiolog
pathogen
cap
may
vari
countri
data
pathogen
distribut
cap
report
western
countri
whilst
data
avail
asian
region
recent
emerg
antimicrobi
resist
major
respiratori
pathogen
especi
pneumonia
anoth
critic
point
appropri
treatment
cap
previou
data
asian
network
surveil
resist
pathogen
ansorp
show
asian
countri
seriou
problem
increas
preval
level
antimicrobi
resist
penicillin
macrolid
pneumococc
isol
although
sever
treatment
guidelin
propos
differ
organis
infecti
diseas
societi
americaamerican
thorac
societi
idsaat
canadian
societi
infecti
diseas
drugresist
streptococcu
pneumonia
drsp
therapeut
work
group
treatment
recommend
cap
asian
countri
base
epidemiolog
inform
pathogen
distribut
antimicrobi
resist
among
major
respiratori
pathogen
asian
region
multin
surveil
studi
ansorp
perform
investig
epidemiolog
aetiolog
pathogen
cap
asian
countri
includ
usual
bacteri
pathogen
atyp
pathogen
well
evalu
clinic
outcom
risk
factor
cap
asian
countri
ansorp
adult
patient
fulfil
follow
criteria
clinic
radiolog
diagnosi
cap
elig
studi
cap
defin
follow
new
progress
infiltr
consolid
pleural
effus
consist
pneumonia
chest
radiographi
perform
within
h
prior
enrol
fever
histori
fever
defin
oral
temperatur
c
least
two
respiratori
sign
symptom
new
increas
cough
purul
sputum
chang
sputum
characterist
auscultatori
find
pulmonari
examin
rale
andor
evid
pulmonari
consolid
dyspnoea
tachypnoea
peripher
white
blood
cell
wbc
count
cellsmm
immatur
neutrophil
leukopenia
total
wbc
count
cellsmm
hypoxemia
partial
pressur
oxygen
arteri
blood
pao
mmhg
patient
breath
room
air
patient
younger
year
age
patient
hospitalis
h
discharg
acut
care
hospit
within
day
patient
organ
transplant
within
month
patient
sever
acut
respiratori
syndrom
sar
known
human
immunodefici
viru
hiv
infect
patient
exclud
studi
enrol
patient
evalu
regard
clinic
radiolog
microbiolog
find
avail
clinic
laboratori
radiolog
inform
record
presenc
follow
comorbid
condit
determin
patient
report
chart
review
bronchopulmonari
diseas
ie
asthma
chronic
obstruct
pulmonari
diseas
interstiti
lung
diseas
congest
heart
failur
coronari
arteri
diseas
malign
cerebrovascular
diseas
renal
diseas
immunosuppress
base
find
risk
class
determin
accord
criteria
pneumonia
patient
outcom
research
team
pport
studi
studi
specif
antibiot
regimen
recommend
use
antimicrobi
agent
centr
record
followup
evalu
done
clinic
radiolog
microbiolog
respons
antimicrobi
therapi
clinic
outcom
measur
mortal
rate
time
enrol
sputum
cultur
blood
cultur
feasibl
serolog
test
atyp
pathogen
perform
microbiolog
evalu
perform
initi
antimicrobi
treatment
sputum
specimen
sampl
respiratori
secret
gram
stain
examin
microscop
presenc
wbc
epitheli
cell
bacteria
purul
measur
microscopi
accept
wbc
squamou
epitheli
cell
result
sputum
cultur
consid
signific
gramstain
criteria
satisfi
given
practic
perform
cost
specif
sensit
three
serolog
kit
chosen
detect
atyp
pathogen
detect
pneumonia
c
pneumonia
enrol
patient
platelia
pneumonia
kit
biorad
marneslacoquett
franc
c
pneumonia
eia
kit
thermo
labsystem
helsinki
finland
use
accord
manufactur
instruct
consist
micropl
use
enzymelink
immunosorb
assay
elisa
kit
detect
immunoglobulin
g
igg
igm
class
antibodi
presenc
igm
antibodi
allow
diagnosi
acut
infect
directli
first
serum
sampl
result
igm
neg
equivoc
igg
test
first
serum
store
igm
test
second
serum
second
blood
sampl
day
sampl
second
titr
igg
increas
twice
compar
first
titr
acut
infect
confirm
detect
legionella
pneumophila
enrol
patient
legionella
urinari
antigen
test
binax
inc
scarborough
use
vitro
rapid
immunochromatograph
assay
qualit
detect
l
pneumophila
serogroup
antigen
urin
specimen
patient
symptom
pneumonia
aetiolog
pneumonia
confirm
one
follow
criteria
met
blood
cultur
yield
bacteri
fungal
pathogen
absenc
appar
extrapulmonari
focu
pleural
fluid
transthorac
needl
aspir
cultur
yield
bacteri
pathogen
seroconvers
ie
fourfold
increas
igg
titr
singl
increas
igm
titr
c
pneumonia
pneumonia
posit
urinari
antigen
l
pneumophila
pneumonia
bacteri
growth
cultur
bronchoalveolar
lavag
bal
fluid
colonyform
unitsml
aetiolog
consid
presumpt
valid
sputum
sampl
yield
one
predomin
bacteri
strain
bacteri
isol
initi
cultur
subject
vitro
test
local
microbiolog
laboratori
usual
isol
sent
central
laboratori
samsung
medic
center
seoul
south
korea
vitro
test
variou
antimicrobi
agent
antimicrobi
suscept
test
perform
broth
microdilut
method
accord
standard
clinic
laboratori
standard
institut
antimicrobi
agent
test
penicillin
amoxicillinclavulan
acid
cefuroxim
ceftriaxon
imipenem
erythromycin
azithromycin
ciprofloxacin
levofloxacin
teicoplanin
vancomycin
student
ttest
use
compar
continu
variabl
fisher
exact
test
compar
categor
variabl
identifi
independ
risk
factor
mortal
stepwis
condit
logist
regress
analysi
use
control
effect
confound
variabl
pvalu
twotail
pvalu
consid
statist
signific
total
case
enrol
studi
centr
januari
decemb
case
exclud
owe
inadequ
medic
record
therefor
total
case
men
women
fulfil
diagnost
criteria
cap
evalu
korea
hong
kong
china
india
singapor
vietnam
taiwan
philippin
demograph
characterist
patient
shown
tabl
mean
age
standard
deviat
patient
year
rang
year
bronchopulmonari
diseas
frequent
underli
diseas
follow
cardiovascular
diseas
malign
neurolog
disord
tabl
smoke
histori
report
patient
patient
histori
prior
antibiot
use
clinic
laboratori
radiolog
find
patient
enrol
summaris
tabl
cough
common
symptom
patient
present
alter
mental
leukocytosi
wbc
azotaemia
blood
urea
nitrogen
mgdl
hypoxaemia
pao
mmhg
arteri
oxygen
satur
sao
also
observ
respect
tabl
multipl
lobe
involv
patient
pleural
effus
found
diseas
sever
pneumonia
patient
classifi
base
port
criteria
time
enrol
patient
belong
follow
class
class
class
ii
class
iii
class
iv
class
v
overal
patient
admit
hospit
patient
admit
intens
care
unit
microbiolog
aetiolog
could
determin
patient
definit
case
presumpt
overal
total
bacteri
pathogen
isol
patient
common
specimen
sourc
sputum
follow
blood
pleu
tabl
serolog
test
pneumonia
c
pneumonia
pair
sera
obtain
patient
respect
posit
serolog
result
obtain
pneumonia
patient
c
pneumonia
urinari
antigen
test
l
pneumophila
urin
sampl
obtain
patient
posit
l
pneumophila
patient
bacteri
pathogen
isol
mix
infect
found
patient
follow
patient
two
differ
pathogen
patient
three
differ
pathogen
patient
four
differ
pathogen
tabl
frequent
combin
pneumonia
c
pneumonia
mix
result
antimicrobi
suscept
test
major
pathogen
summaris
tabl
pneumococc
isol
avail
isol
suscept
penicillin
penicillin
intermedi
minimum
inhibitori
concentr
mic
gml
penicillin
resist
mic
gml
resist
rate
erythromycin
cefuroxim
ceftriaxon
respect
pneumococc
isol
resist
vancomycin
levofloxacin
h
influenza
isol
isol
resist
azithromycin
isol
suscept
amoxicillinclavulan
acid
ciprofloxacin
imipenem
k
pneumonia
isol
resist
rate
cefuroxim
ceftriaxon
respect
k
pneumonia
isol
suscept
ciprofloxacin
imipenem
tabl
case
antimicrobi
therapi
initi
within
h
enrol
five
hundr
fortytwo
patient
receiv
combin
therapi
initi
empir
antimicrobi
therapi
thirdgener
cephalosporin
macrolid
frequent
prescrib
combin
regimen
follow
penicillin
macrolid
thirdgener
cephalosporin
fluoroquinolon
penicillin
aminoglycosid
four
hundr
thirteen
patient
receiv
monotherapi
empir
antimicrobi
therapi
penicillin
common
agent
follow
fluoroquinolon
thirdgener
cephalosporin
secondgener
cephalosporin
macrolid
clinic
outcom
evalu
case
submit
relev
data
outcom
analysi
overal
mortal
rate
patient
evalu
port
classif
mortal
rate
class
class
ii
class
iii
class
iv
class
v
regard
final
clinic
outcom
clinic
improv
without
modif
antibiot
clinic
improv
modif
antibiot
death
due
pneumonia
aggrav
observ
whilst
clinic
outcom
undetermin
case
univari
analys
risk
factor
mortal
includ
old
age
nurs
home
resid
malign
cardiovascular
diseas
renal
diseas
prior
hospitalis
alter
mental
respiratori
rate
systol
blood
pressur
mmhg
puls
rate
leukocytosi
azotaemia
hypoxaemia
hyponatraemia
high
glucos
level
low
haematocrit
multilobar
involv
pleural
effus
mechan
ventil
p
tabl
multivari
analysi
use
logist
regress
model
includ
variabl
associ
mortal
univari
analysi
p
show
nurs
home
resid
mechan
ventil
malign
cardiovascular
diseas
respiratori
rate
hyponatraemia
independ
risk
factor
mortal
p
tabl
current
data
provid
comprehens
evalu
caus
outcom
patient
cap
asian
countri
larg
prospect
multicentr
studi
ansorp
studi
highlight
sever
characterist
cap
asian
countri
high
preval
pneumonia
aetiolog
pathogen
rel
high
preval
mix
infect
bacteria
atyp
pathogen
antimicrobi
practic
treatment
cap
clinic
outcom
risk
factor
mortal
demograph
characterist
patient
studi
similar
previou
data
region
approxim
enrol
patient
least
one
comorbid
condit
includ
bronchopulmonari
disord
cardiovascular
disord
malign
neurolog
disord
signific
differ
clinic
present
cap
caus
typic
bacteri
pathogen
atyp
pathogen
data
shown
studi
aetiolog
pathogen
identifi
case
base
microbiolog
serolog
studi
rel
low
percentag
case
identifi
aetiolog
might
due
prior
antibiot
use
cultur
difficulti
obtain
adequ
sputum
specimen
approxim
case
receiv
antimicrobi
therapi
enrol
studi
among
identifi
aetiolog
pneumonia
common
pathogen
previous
report
region
vitro
resist
penicillin
macrolid
antimicrobi
agent
pneumococc
isol
studi
consist
find
previou
ansorp
studi
asian
countri
particular
high
preval
erythromycin
resist
high
mic
level
would
preclud
use
macrolid
firstlin
agent
treatment
cap
mani
asian
countri
preval
rate
pneumonia
c
pneumonia
asian
countri
compar
region
approxim
cap
case
asian
countri
caus
atyp
pathogen
interestingli
howev
incid
cap
caus
legionella
spp
extrem
low
studi
although
incid
legionella
pneumonia
low
studi
report
one
common
atyp
pathogen
cap
around
world
anoth
import
find
studi
rel
high
incid
mix
infect
typic
bacteria
atyp
pathogen
signific
frequenc
mix
infect
cap
mainli
mix
bacterialvir
infect
increasingli
report
although
evalu
viral
aetiolog
studi
cap
case
caus
multipl
pathogen
pneumonia
c
pneumonia
pneumonia
pneumonia
epidemiolog
find
import
clinic
practic
type
mix
infect
may
result
treatment
failur
monotherapi
agent
tuberculosi
tb
diagnos
patient
show
clinic
present
bacteri
pneumonia
tb
consid
possibl
caus
cap
especi
area
tb
endem
select
appropri
antimicrobi
agent
essenti
treatment
cap
base
suspect
microorgan
risk
factor
sever
ill
accord
recent
idsaat
guidelin
macrolid
doxycyclin
fluoroquinolon
recommend
monotherapi
option
treat
outpati
cap
howev
macrolid
doxycyclin
may
appropri
option
treatment
outpati
cap
asian
countri
resist
macrolid
tetracyclin
preval
also
singl
use
agent
would
result
clinic
failur
cap
caus
multipl
agent
includ
atyp
pathogen
current
studi
show
regardless
microorgan
risk
factor
sever
cap
combin
regimen
especi
thirdgener
cephalosporin
macrolid
one
common
regimen
use
treatment
patient
cap
asian
countri
overal
mortal
rate
cap
onehalf
case
die
uncontrol
pneumonia
current
studi
could
identifi
risk
factor
death
would
similar
document
studi
among
independ
risk
factor
identifi
studi
hyponatraemia
common
complic
present
time
admiss
cap
associ
sever
ill
studi
may
limit
first
number
case
cap
countri
rel
small
may
repres
nation
statu
pathogen
distribut
antimicrobi
resist
pathogen
second
sinc
evalu
viral
aetiolog
could
estim
true
incid
mix
infect
conclus
data
studi
could
provid
better
understand
aetiolog
risk
factor
clinic
characterist
outcom
cap
asian
countri
given
preval
major
bacteri
pathogen
antimicrobi
suscept
well
incid
atyp
pathogen
mix
infect
appropri
antimicrobi
option
could
recommend
asian
countri
